NAVIPOINT GENOMICS LLC

NAPERVILLE, IL · Biotech · Private

Cloud-based bioinformatics analysis platform for precision oncology genomic data integration and analysis

Claim this profile

Follows are private to you and power your alerts

Updated · navipointgenomics.com

Sector
Biotech
Headquarters
NAPERVILLE, IL
Total capital
$3.8M
Federal grants
$1.9M
2 awards · 2017
Rank in peer group#10 of 37
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$1.9M
2 awards · Health and Human S
Rank in Biotech#139 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201720182019202020212022FEDERAL ↑EQUITY ↓Cumulative $2.2M$225K$252K$1.7M
201720182019202020212022FEDERAL ↑EQUITY ↓Cumulative $2.2M$225K$252K$1.7M

Latest events

  • Federal contractHealth and Human S · Topic 407 Title: Cloud-based Software For The Cancer Research Data Commons Project Title: Collaborate In The Cloud To Enable Precision Oncology$1.7M
  • Federal contractHealth and Human S · SBIR Phase I Topic 407 - Cloud-based Software For The Cancer Research Data Commons.$252K
  • Federal grantNSF · Phase I · STTR Phase I: Development of a high-performance clinical genomics analysis platform to support precision medicine$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 37 peers

Line = median

Biotech · Platform

  • Federal grants#10 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Navipoint Genomics, LLCShares a founder: Dinanath Sulakhe
  • BUFFALO BIOLABS, LLCSimilar federal contract value in Biotech · $2M in contracts
  • PEARL BIO, INC.Similar federal contract value in Biotech · $1.9M in contracts
  • GLYCAN THERAPEUTICS CORPORATIONSimilar federal contract value in Biotech · $1.9M in contracts
  • IDBIOLOGICS INCSimilar federal contract value in Biotech · $1.9M in contracts
  • PHOTOLITEC LLCSimilar federal contract value in Biotech · $1.9M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .